Australian Mother Turned Away After Asking For Help Cuts Her Wrists & Baby’s Throat

Sucharitta Milton

Sucharitta Milton

Australian Husband/Father Blames Hospital for Wife/Mother’s Attempted Suicide & Attempted Murder of Three Week Old Baby

To make you aware of the fact that America is not the only place we have so many mothers on these medications killing, or attempting to kill, their children while under the influence of antidepressants here is a case brought to us from our New Zealand Director of the International Coalition for Drug Awareness, Tracy Lee who lost her own child due to antidepressant-induced suicide:

David Milton said he took his wife, Sucharitta, to Southland Hospital at 3am on Sunday because she was in “absolute agony”.

She had been “like a zombie” and in extreme pain with multiple stitches since the birth of their daughter.

But the hospital sent her home just three and a half hours later after undergoing several tests and being told she had post-natal depression and mastitis.

On Sunday night Sucharitta began passing out and Mr Milton rang their midwife, who had been visiting weekly, to tell her about Sucharitta’s symptoms.

Her husband said the doctor’s attitude was absolutely disgusting when the hospital sent her home telling her to contact her GP the following morning. But by Monday morning their home was a crime scene after his wife cut their three week old baby’s throat and her own wrists. She had cut her wrists so deeply she cut both tendons and ligaments.

Luckily the baby is doing much better, breathing on her own and smiling when she hears her father’s voice.

Of course it would seem to me they would have immediately prescribed an antidepressant as regular procedure for treatment of the diagnosed post partum depression. And that could have been the reason for both her beginning to pass out on Sunday evening and the murder/suicide attempt hours later.

WARNING: In sharing this information about adverse reactions to antidepressants I always recommend that you also give reference to my CD on safe withdrawal, Help! I Can’t Get Off My Antidepressant!, so that we do not have more people dropping off these drugs too quickly – a move which I have warned from the beginning can be even more dangerous than staying on the drugs!

The FDA also now warns that any abrupt change in dose of an antidepressant can produce suicide, hostility or psychosis. And these reactions can either come on very rapidly or even be delayed for months depending upon the adverse effects upon sleep patterns when the withdrawal is rapid! You can find the CD on safe and effective withdrawal helps here: http://store.drugawareness.org/

Ann Blake Tracy, Executive Director,
International Coalition for Drug Awareness
www.drugawareness.org & http://ssristories.drugawareness.org
Author: ”Prozac: Panacea or Pandora? – Our Serotonin Nightmare – The Complete Truth of the Full Impact of Antidepressants Upon Us & Our World” & Withdrawal CD “Help! I Can’t Get Off My Antidepressant!”

Original articles:

http://www.stuff.co.nz/national/crime/9127120/Babys-father-blames-hospital

http://www.stuff.co.nz/national/health/9130882/Mothers-care-to-be-reviewed-after-baby-hurt

562 total views, 12 views today

SSRI: 100-500% Increased Risk of Heart Birth Defects If Taken In Early Pregnancy

NOTE FROM Ann Blake-Tracy (www.drugawareness.org): This new study SHOULD stop the Mother’s Act dead in its tracks! The Mother’s Act is designed to medicate pregnant and nursing mothers for depression and we know what they medicate them with – these drugs that they have just shown amazingly damaging effects upon the heart of the fetus!

ANY YOUNG WOMAN WHO INTENDS TO HAVE A FAMILY SHOULD BE WARNED OF THIS POSSIBILITY OF SERIOUS LIFE THREATING BIRTH DEFECTS IN HER OFFSPRING BEFORE EVER BEING STARTED ON AN SSRI ANTIDEPRESSANT!! Marketing these drugs to this age group should be considered criminal when you look at what this study shows to be the risks to the children born to these mothers.

And if you think this does not affect you, think again. You need to see what these children go through (if they survived their mother’s use of these drugs) throughout their lives due to their mother’s use of these drugs! Who do you think ends up paying the bills for the numerous reconstructive surgeries, the lifetime of medications and medical treatment? We do. All of us in higher insurance rates, disability payments, etc., etc., etc.

PLEASE CAREFULLY EXAMINE THE FOLLOWING RESULTS OF THIS STUDY AND SHARE IT WITH EVERYONE YOU KNOW!!! Doing so may spare at least one baby from this horror.

Here is just one small example: http://bigpharmavictim.blogspot.com Manie’s mother was given Paxil and assured it would be okay as so many mothers are told. Her infant son, Manie, was born with Transposition of the Great Arteries and had to have open heart surgery when he was only 8 days old. The surgery lasted 12 hours.
___________________________

Paragraph one reads: “If you take antidepressants such as fluoxetine (marketed as Prozac) early in your pregnancy, you may be doubling the risk that your newborn will be born with a heart defect, according to a new study.”

Paragraph four reads: “Along with fluoxetine, sertraline (marketed as Zoloft) and citalopram (marketed as Celexa) seemed to increase the risk more than others, as did using more than one antidepressant at a time, according to the report in the September 25th Online First issue of BMJ.”

Paragraph six reads: “Sertraline [Zoloft] more than tripled the risk, while citalopram [Celexa] more than doubled it. Using more than one SSRI nearly quintupled the risk of the heart defect.”

http://www.reuters.com/article/healthNews/idUSTRE58O39F20090925

Antidepressants in pregnancy up heart defect risk
Fri Sep 25, 2009 9:58am EDT Email | Print | Share| Reprints | Single Page[-] Text [+]

By Anthony J. Brown, MD

NEW YORK (Reuters Health) – If you take antidepressants such as fluoxetine (marketed as Prozac) early in your pregnancy, you may be doubling the risk that your newborn will be born with a heart defect, according to a new study.

However, the vast majority of children born to women who take such antidepressants – known as selective serotonin reuptake inhibitors (SSRIs) – do not have such defects, the researchers are quick to note.

Earlier studies have tied SSRIs during pregnancy to heart defects, but also to even more serious birth defects. According to the new study of nearly half a million children born in Denmark between 1996 and 2003, however, only heart defects are likely to be associated with the antidepressants, note co-author Dr. Lars Henning Pedersen, from Aarhus University, Denmark, and colleagues.

Along with fluoxetine, sertraline (marketed as Zoloft) and citalopram (marketed as Celexa) seemed to increase the risk more than others, as did using more than one antidepressant at a time, according to the report in the September 25th Online First issue of BMJ.

Overall, SSRI use in early pregnancy, defined as 28 days before to 112 days after conception, doubled the risk of a particular kind of heart defect involving a piece of tissue that separates parts of the heart.

Sertraline more than tripled the risk, while citalopram more than doubled it. Using more than one SSRI nearly quintupled the risk of the heart defect.

However, the number of children born with such defects was still quite small: For about every 250 pregnant women who did not take SSRIs, one infant was born with the defect, while about two were born with the defect for every 250 women who took one SSRI, and four for every 200 mothers who took more than one.

Pedersen told Reuters Health that the results surprised the team.

Still, in an accompanying editorial, Dr. Christina Chambers, from the University of California, San Diego, comments that doctors and patients “need to balance the small risks associated with SSRIs against those associated with undertreatment or no treatment.”

SOURCE: BMJ, online September 25, 2009.

1,971 total views, 3 views today

4/18/2001 – Paxil Is Approved for Anxiety Disorder?!

Incredible! The FDA continues to undermine the health and safety of America
with this latest approval – as if doctors had ever noticed that Paxil was NOT
approved for anxiety before this. They have been handing it out like candy
for any and everything they can think of for years.

What is so disconcerting about this is that anxiety can be caused by two
disorders in particular – low blood sugar (hypoglycemia) or seizure activity.
Paxil can trigger both hypoglycemia and seizures. So, if a doctor does not
check to see if the patient is suffering from either of those disorders (and
that is hard to do in the three minutes it has been reported that it usually
takes for a doctor to recommend one of these SSRIs), the Paxil could throw
the patient into serious blood sugar problems or seizures.

Did the FDA consider any of that information before this approval?
Considering the number of drugs pulled from the market in the last few years,
chances are slim that they did.

So now many more ethical doctors who were not handing out Paxil for anxiety
before will feel that with the FDA’s approval they can do so without worry.
No one has warned them that the patient will be lucky to live through the
horrific withdrawal though. As Dr. Nancy Snyderman pointed out in the 20/20
special last August, it may take patients up to a year to get off this drug
safely. (Something I have been saying for years.)

Once again we have the FDA to thank. Isn’t it long past time for them to be
sued for the lives being lost to their incompetence? I guess I just see too
many families wiped out in murder/suicides and too many mothers killing their
children and too many school shootings and workplace violence incidences
induced by Paxil to be patient any longer about this.

Ann Blake-Tracy, Executive Director,
International Coalition For Drug Awareness
www.drugawareness.org

http://www.nytimes.com/2001/04/17/business/17GLAX.html?searchpv=nytToday

April 17, 2001

Paxil Is Approved for Anxiety Disorder

By BLOOMBERG NEWS

WASHINGTON, April 16 (Bloomberg News) — Glaxo- SmithKline P.L.C. has won the
Food and Drug Administration’s approval to market its antidepressant Paxil
for treating general anxiety disorder, a new use for the drug.

That makes Paxil the first drug in its class to be approved for the
condition, which affects about 10 million Americans and involves excessive,
often debilitating worrying, the company said today.

“Generalized anxiety disorder can paralyze sufferers with uncontrollable
worry, devastating people’s lives,” said Jack Gorman, a professor in the
department of psychiatry at Columbia University. “Paxil provides a new
alternative to help sufferers regain control over their lives.”

Paxil is already approved for treating depression, obsessive- compulsive
disorder, social phobia and panic disorder. With sales of $2.4 billion, Paxil
was the world’s seventh top-selling drug in 2000, according to figures
compiled by the prescription drug tracker IMS Health Inc.

New indications are important to the company’s efforts to defend Paxil, which
belongs to same class as Eli Lilly’s Prozac, against generic competitors.

In a different class of medicines, two antidepressants, Effexor from American
Home Products and Buspar from Bristol-Myers Squibb, are also approved to
treat general anxiety disorder.

587 total views, no views today